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ABSTRACT   
1,3,4-Thiadiazole and their derivatives exhibit a broad spectrum of biological effectiveness like antimicrobial, antiinflammatory, antitubercular, antidiabetic, 
anticancer, antidepressant, anti- parkinson, hypoglycaemic, anti-hypertensive and diuretic activity. This review provide a broad view of chemistry of 1,3,4-
thiadiazole system and it includes the literature survey on methods of preparation and pharmacological activities of 1,3,4-thiadiazole moiety. As a result, 
compounds containing 1,3,4-thiadiazole were attracted much attention in the field of medicines. 
Keywords: 1,3,4-thiadiazole, biological effectiveness. 
 
INTRODUCTION 
Several five membered aromatic systems having three hetero 
atoms at symmetrical position have been studied because of 
their interesting physiological properties. Thiadiazole is a 5-
membered  ring  system  containing  two  nitrogen  and  one 
sulphur atom. They occur in nature in four isomeric forms 
viz. 1,2,3-thiadiazole; 1,2,5-thiadiazole; 1,2,4-thiadiazole and 
1,3,4-thiadiazole.  The  thiadiazoles  have  occupied  an 
important  place  in  drug  industry.  1,3,4-Thiadiazoles  have 
wide applications in many fields. The earliest uses were in 
the  pharmaceutical  area  as  antibacterial  with  known 
sulphonamides drugs. Some of the later uses are as antitumor 
and anti-inflammatory agents, pesticides, dyes, lubricants and 
analytical reagents. The literature review showed that 1,3,4-
Thiadiazole  and  its  derivatives  possess  wide  range  of 
therapeutic  effectiveness  like  antimicrobial, 
antiinflammatory, antitubercular, anticonvulsant, antidiabetic, 
anticancer,  antidepressant,  antiparkinson,  hypoglycaemic, 
antihypertensive and diuretic activity. 
Antimicrobial Activity 
Salimon et al
1 carried out the successful synthesis of some 
new 2,5-(dithioacetic acid)-1,3,4-thidiazole 1(a) and 2,5-di-
[5-amino-1,3,4-thiadiazole-2-thiomethyl]-1,3,4-thiadiazole 
1(b)  which  were  screened  for  their  in  vitro  antibacterial 
activities against the Gram-positive (S. aureus, S. cerevisiae 
and  C.  diphtheriae)  and the  Gram-negative,  (E.coli and  P. 
aeruginosa)  bacteria  .
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Some  new  subsituted-2,4-diphenyl-5-imino-1,3,4-thiadiazole  derivatives  were  synthesized  by  M.Asif  et  al
2  and  all  the 
compounds were evaluated for their in vitro antibacterial activity against two Gram negative strains (Escherichia coli and 
Pseudomonas aeruginosa) and two Gram positive strains (Bacillus cereus and Staphylococcus aureus) and their minimum 
inhibitory  concentration  (MIC)  were  determined.  The  newly  synthesized  compounds  exhibited  promising  antimicrobial 
activities. Tanveer Ahmad et al. IRJP 2012, 3 (3) 
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  Compounds         R1  R2  R3  R4 
      (2a)              H           H               H                H 
    (2b)              H           H              NO2  NO2 
    (2c)              Cl          H               H                H 
    (2d)              Cl          H              NO2  NO2 
    (2e)              H           Cl              H                H 
    (2f)               H          Cl              NO2  NO2 
    (2g)      H           NH2  H                H 
    (2h)              H           NH2  NO2  NO2 
 
Mehta et al
3 synthesized a series of 2-Arylsulfonamido-5-(Benzthiazol-2’yl-Thiamethyl)-1,3,4-thiadiazoles and were screened 
for antibacterial activity against gram (+ve) Bacillus megaterium, B.subtilis  and gram(-ve) Escherichia coli and A.aerogens 
and antifungal activity against A.awamory.Compounds showed good antibacterial activity and moderate antifungal activity. 
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3(a –h) 
R=Phenyl,4-Chlorophenyl, 4-Iodophenyl,4-Anisyl,3-Carboxyphenyl, 3-Carboxy-4-chlorophenyl, 3-Carboxy-6-chloropheny, 3-
Carboxy-4-methoxyphenyl. 
 
Barve Ashutosh et al
4 have synthesized a series of eight novel 1, 3, 4-Thiadiazol-2-Amine (4a-h) derivatives and investigated 
for  in  vitro  antibacterial  and  antifungal  activity  against  various    Gram-positive  bacterial  strains:  Bacillus  Subtillis; 
Staphylococcus  aureus,  Gram-negative  bacterial  strains:  Escherichia  coli;  Pseudomonas  aeruginosa,  Fungal  strains 
Saccharomyces cerevisiae; Aspergillus niger, Candida albicans.It is showed that compounds (4a), (4e), (4f) and (4h) exhibited 
antibacterial and antifungal activity.  
N N
S
N N
S
(CH2)n NH2
NH2
 
n=1,2,3,4......8                             4(a-h) 
  
Madhav et al
5 have been synthesized a series of new 2-(substituted benzalamino)-5-(8-quinolinoxy methyl)-1,3,4-thiadiazoles 
and screened for their antimicrobial activity. Among all the compounds,compound 5g (R = 4-NO2) has been found to be 
greater inhibitory effect against four strains of bacteria, followed by compound 5f (R= 2-Cl) whereas rest of the compounds 
were mild to moderately active. Tanveer Ahmad et al. IRJP 2012, 3 (3) 
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5(a-h) 
R= 3-OCH34-OH, 2-OH ,4-OCH3 , 3-OCH34-OCH3 ,4-N,N-dimethyl, 2-Cl, 4-NO2 , -H 
 
Rajiv  Dua  et  al
6  have  synthesized  several  new  2-(2'-substitutedbenzylidene-hydrazino-acetyl)-mercapto-5-methyl-1,3,4-
thiadiazoles,6(a-n)  and  2-[2'-{4-substituted-aryl-3-chloro-2-oxo-azetidine}-acetyl-amino-mercapto]-5-methyl-1,3,4-
thiadiazoles,7(a-n).  All  the  synthesized  products  were  evaluated  for  their  antibacterial  activity  against  Bacillus  substilis, 
Escherichia coli. Klebsiella pneumoniae and Streptococcus aureus bacteria and antifungal activity against Aspergillus niger, 
Aspergillus flavus, Fusarium oxisporium and Trichoderma viride fungi respectively.They have shown significant antibacterial 
and antifungal activity. 
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The  research  study  by  Amir  et  al
7  report  the  synthesis  and  antimicrobial  activity  of    new  2-aryl-5-(6'  -chloro-1',3'-
benzothiazole-2-yl-amino)-1,3,4-thiadiazoles  (8a-j)  and  4-(4'  -arylidene)  -2-phenyl-1-(6'-chloro-1',3'-benzothiazol-2-yl-
thiourido)-4,5-dihydroimidazolinones (9a-e).All the compounds showed significant antimicrobial activity. 
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8(a-j) 
Ar=phenyl,4-Chiorophenyl,2,4-Dichlorophenyl, 4-Nitrophenyl, 2-Aminopheny,2,4-Dichlorophenoxymethyl,2-
Napthylmethyl,4-Methoxyphenyl,2-Acetoxyphenyl,3-Pyridyl. 
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9(a-e) 
R= Phenyl,4-Chiorophenyl,4-Fluorophenyl, 4-N,N-dimethyl phenyl,3-Indolyl. 
 
Sabir Hussain et al
8 have synthesized some 4-amino-2-{5-[(4-substituted phenyl)amino]-1,3,4-thiadiazole-2-yl} phenol 10(a-g) 
evaluated for their antibacterial and antifungal activity. The compounds showed significant antibacterial activity against S. 
aureus (gram-positive) and E.coli (gram-negative) bacteria and antifungal activity against A. niger fungi. Compounds 10c, 10f  
exhibited promising antibacterial activity against S. aureus and A. niger. 
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Ar = 4-Methylphenyl,4-Methoxyphenyl,4-Chlorophenyl,2,5-Dimethylphenyl,3-Chloro-4-fluorophenyl,4-Bromophenyl. 
  
Parmar et al
9 synthesized some new and biologically active [1,2,4] triazolo[3,4-b][1,3,4] thiadiazole-2-aryl thiazolidinone-4-
ones by reaction of Schiff bases with mercapto acetic acid in presence of THF with adding anhydrous ZnCl2. The compounds 
have been evaluated for antibacterial activity against B. subtilis, S. aureus, P. aeruginosa and E. coli. 
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11(a-h) 
Ar =  -C6H5 ,4-OCH3-C6H4 , 4-OH-C6H4 , 2-OH-C6H4, 4-CH3-C6H4 , 
O
C6H5
-
O ,4-OH-3-OCH3-C6H3 , 4-OC2H5-3-
OC2H5-C6H3 . 
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M.Vedavathi et al
10 synthesized Fluorobenzothiazole incorporated with 1,3,4-thiadiazole derivatives and evaluated for their 
anti-microbial activity. Significant antimicrobial activities were observed for members of this series. 
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R’ = Morpholine(a),Piperazine(b) 
S
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R 13(a-g)
 
R = o, m, p nitro aniline (a-c) 
= o, m, p chloro aniline (d-f) 
= aniline (g) Tanveer Ahmad et al. IRJP 2012, 3 (3) 
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R= o-anisidine, m-anisidine, p-anisidine 
 
Padmaja et al
11 have been synthesized a new class of pyrrolyl/pyrazolyl arylaminosulfonyl methyl , 1,3,4-thiadiazoles and 
tested for antimicrobial activity. The antibacterial activity was carried out against Staphylococcus aureus, Bacillus subtilis 
(Grampositive  bacteria)  and  Pseudomonas  aeruginosa,  Klebsiella  pneumoniae  (Gram-negative  bacteria)  and  antifungal 
activity evaluated against Penicillium chrysogenum, Curvularia lunata and Aspergillus niger. 
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R = H, Me, Cl 
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R = H, Me, Cl Tanveer Ahmad et al. IRJP 2012, 3 (3) 
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Cherkupally  et  al
12  synthesized  a  new  series  of  6-(aryl/heteryl)-3-(5-methyl-1-phenyl-1H-4-pyrazolyl)[1,2,4]triazolo[3,4-
b][1,3,4]thiadiazoles 18(a—j). All the synthesized compounds were tested  for in vitro activities against certain strains of 
bacteria such as Staphylococcus aureus, Bacillus subtilis, Escherichia coli and fungi such as Aspergillus niger, Aspergillus 
nodulans, Alternaria alternate. Compounds having 4-chlorophenyl (18d), 4-aminophenyl (18f), 4-nitrophenyl (18h) and 3-
pyridyl (18i) substituents at 6-position of thiadiazole ring, showed marked inhibition of bacterial and fungal growth. The other 
new compounds also showed appreciable activity against the test bacteria and fungi. 
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Ar =  phenyl, 4-methylphenyl, 4-methoxyphenyl, 4-chlorophenyl, 2-chloropheyl, 4-aminophenyl, 
4-hydroxyphenyl, 4-nitrophenyl, 3-pyridyl, 4-pyridyl. 
 
K.R.Alagawadi et al
13 synthesized a new 2,4-thiazolidinediones derivatives bearing imidazo[2,1-b][1,3,4] thiadiazole moeity. 
All  compounds  were  evaluated  for  their  preliminary  in  vitro  antibacterial  and  antifungal  activity  against  Gram-positive 
Staphylococcus  aureus,  Enterococcus  faecalis,Gram-negative  Escherichia  coli  ,  Pseudomonas  aeruginosa  bacteria  and 
Candida albicans, Aspergillus flavus , Aspergillus niger , and Cryptococcus neoformans fungi. The results revealed that most 
of the compounds showed high or moderate biological activity against tested microorganisms. 
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19(a-g) Tanveer Ahmad et al. IRJP 2012, 3 (3) 
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Ar = C6H5 ,4-CH3-C6H4 ,4-OCH3-C6H4 , 4-NO2-C6H4 ,4-Br-C6H4 , 4-Cl-C6H4 ,2,5-(OCH3)- C6H3. 
 
Vasoya et al
14 synthesized 2-(3′-Chloro-5′-phenoxybenzo[b]thiophen-2′-yl)-5-arylamino-1,3,4-thiadiazole derivatives (21a-h) 
by the cyclization of arylthiosemicarbazides with concentrated sulphuric acid. All the compounds were screened for their 
antimicrobial activity against various microorganisms. 
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21(a-h) 
R = -C6H5,  3-Cl-C6H4,  4-Cl-C6H4 , 2-CH3-C6H4 ,4-CH3-C6H4 ,  2-OCH3- C6H4 ,  4-OCH3-C6H4 , 2-NO2- C6H4 
 
Pratibha  Singh  et  al
15  have  been  synthesized  some  thiadiazole  derivatives  by  incorporating  azetidinyl  and  thiazolidinyl 
moieties  at  its  2-position  such  as  5-(p-methoxyphenyl)-[2-substituted  benzylidenylimino]  1,3,4-thiadiazole  22(a-e),  5-(p-
methoxyphenyl)-[2-(3'-chloro-2'-oxo-4'-substituted aryl-1’-azetidinyl)]-1,3,4-thiadiazole 23(a-e) and 5-(p-methoxyphenyl)-[ 2-
(2'-substituted aryl-4'-oxo-1',3'-thiazolidin-3'-yl)]-1,3,4-thiadiazole 24(a-e). 
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R = 4-OH-C6H4 , 4-OCH3-C6H4 , -C6H5 , 4-Cl-C6H4 , 4-N(CH3)2-C6H4 Tanveer Ahmad et al. IRJP 2012, 3 (3) 
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Pramila Shah et al
16 synthesized formazans from Mannich base of 5-(4-chlorophenyl amino)-2-mercapto-1,3,4-thiadiazole. All 
the compounds (25a-g) were screened for their in vitro antibacterial activity against Escherichia coli and Salmonella typhi. 
Antifungal activity was conducted against Aspergillus niger, Penicillium sp. and Candida albicans 
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25a : R = 2-chloro, VIb : R = 3-methoxy, 4-hydroxy 
25a-b : R = 2-chloro, R1 = 4-nitro, 2-methyl-4-nitro 
25c-e : R = 2-chloro, R1 = hydroxyl, amino, guanidino 
25f-g : R = 3-methoxy, 4-hydroxy, R1 = pyrimidinyl, 4,6 dimethyl pyrimidinyl 
 
Arvind et al
17 synthesized a series of new 5-substituted-[1,3,4-thiadiazole-2-yl] benzamide. 
Antimicrobial activity was carried out using bacterial strain Staphylococcus aureus (gram +ve), E. Coli (gram -ve) and A. 
niger. All compounds have shown moderate antimicrobial activity against all the organism. 
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26(a-g) 
   
R=C6H5, 2- Cl- C6H4, 3- Cl- C6H4, 4- Cl- C6H4,2- NO2C6H4,3- NO2-C6H4,4- NO2- C6H4 
 
Profire et al
18 synthesized a new 1,3,4-thiadiazole derivatives ( 27a-e) containing a D,L-methionine moiety  by intramolecular 
cyclization of 1,4-disubstituted thiosemicarbazides in acid and alkaline media, respectively. The potential antimicrobial effects 
of the synthesized compounds were investigated using the Staphylococcus aureus, Bacillus antracis, Bacillus cereus, Sarcina 
lutea and Escherichia coli strains. The newly synthesized compounds exhibited promising activities against Bacillus antracis 
and Bacillus cereus. 
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R= -CH3, -C6H5 , 4-CH3-C6H4, 4-Br-C6H4 ,-CH2-CH=CH2. 
 
Dogan  et  al
19  synthesized  the  two  new  series  of    2,5-disubstituted-1,3,4-thiadiazoles.  All  the  synthesized  products  were 
evaluated for their antibacterial activity against Bacillus substilis, Escherichia coli. P.aeruginosa and Streptococcus aureus 
bacteria and antifungal activity against Candida.albicans fungi respectively.They have shown significant antibacterial and 
antifungal activity. 
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29(a-j)
 
R= ethyl (a), phenethyl (b), phenyl (c), p-bromophenyl (d), p-chlorophenyl (e), p-fluorophenyl (f), m-fluorophenyl(g), p-
methoxyphenyl (h), p-methylphenyl (i), m-trifluoromethylphenyl (j). 
 
Gilani et al
20 synthesized a series of 6-substituted-1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazole (30a-g) derivatives of isoniazid in 
satisfactory yield and pharmacologically evaluated for their in vitro antimicrobial activity. A majority of the tested compounds 
showed good to moderate antimicrobial activity against all tested pathogenic bacterial and fungal strains. 
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R= -C6H5,  2-Cl-C6H4, 2,4-Cl-C6H3, 2-CH3-C6H4, 2-OCOCH3-C6H3,  -OC6H5 , 4-NO2-C6H4 
 
Demirbas  et  al
21  synthesized  4-Amino-2-[(5-anilino-1,3,4-thiadiazol-2-yl)methyl]-5-(4-chlorophenyl)-2,4-dihydro-3H-1,2,4- 
triazol-3-one (31a) and 4-Amino-5-(4-chlorophenyl)-2-({5-[methyl(phenyl)amino]-4,5-dihydro-1,3,4-thiadiazol-2-yl} methyl)-
2,4-dihydro-3H-1,2,4-triazol-3-one (31b).These synthesized compounds were evaluated for antimicrobial activity.Compound 
31a showed good antimicrobial activities against the test microorganisms as compared with ampicillin. 
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Yousif et al
22 synthesized novel tetra compound Schiff base by condensation of 1,2,4,5-tetra (5-amino-1,3,4-thiadiazole-2-
yl)benzene  with  different  aromatic  aldehydes.  All  compounds  (32  a-h).  Were  screened  for  antibacterial  (Staphylococcus 
aureus, Staphylococcus epidermidis, icrococcus luteus, Bacillus cereus, Escherichia coli, and Pseudomonas aeruginosa) and 
antifungal (Aspergillus niger and Aspergillus fumigatus) activities.  
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32(a-h) 
        
R = p-H, p-CH3, p-OH, o-H, p-NO2, p-Br, p-OCH3, p-Cl 
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Lamani et al
23 synthesized novel methylene bridged benzisoxazolyl imidazo[2,1 b][1,3,4] thiadiazoles (33a-c) and revealed for 
their antibacterial and antifungal activities. Allcompounds having nitroso, bromo, thiocynato exhibited significant antibacterial 
and antifungal activities. 
 
N
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S
N
R  
(33a-c) 
R = Br, NO, SCN 
 
Bahram et al
24 introduced the synthesis and antibacterial activity of a new series of 2-(1- methyl-4 -nitro-1H-imidazol-5-
ylsulfonyl)-1,3,4-thiadiazoles (34a-c). Three compounds were tested in vitro against a panel of microorganisms including gram 
negative and gram-positive bacteria. Compound (34b) with 5-(5-nitrofuran-2-yl)-residue on 1,3,4- thiadiazole scaffold had 
shown  promising  antibacterial  activities  against  gram-positive  bacteria  including  Staphylococcus  aureus,  Staphylococcus 
epidermidis and Bacillus subtilis. 
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B.Gowramma et al
25 synthesized a series of 1, 3, 4-thiadiazole derivatives. All the compounds were evaluated for antibacterial 
and antifungal activities. Most of the compounds have shown significant antibacterial and antifungal activity when compared 
with the standard drugs. 
N N
S Ar NHCH2R
 
35(a-m) 
R = C6H6N & C6H5NCl 
Ar = - C6H5, - C6H4OH, - C6H4N(CH3)2 , - C6H4Cl, - C6H4NO2, - C4H3S 
 
Kadi et al 
26 synthesized a new series of 1-adamanyl-1,3,4-thiadiazole derivatives (36-37) and tested for in vitro antimicrobial 
activities  against  a  panel  of  gram-positive  and  gram-negative  bacteria  and  the  pathogenic  fungus  Candida  albicans. 
Compounds (36) and (37) were found to show marked activity against gram-positive bacteria whereas compound (37) was 
highly active against the tested gram-negative bacteria. However Compounds (36) and (37) were found to show weakly or 
moderate activity against C. Albicans. 
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CONCLUSION 
This literature review reveals that 1, 3, 4 Thiadiazole have diverse biological activity, and very simple synthetic process too. It 
has shown the good  anti-microbial activities. By the present scenario it can be concluded that 1, 3, 4 Thiadiazole have 
remarkable anti –microbial activity. 
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